Details For Selected Brain Tumor Treatment
Sponsored By
Cleveland Clinic Brain Tumor and Neuro-Oncology Center
Please Click On The Above Banner For More Details
Braintumor Website

Back to New Treatments List Back to New Treatments List

Treatment Name: Study of a Retroviral Replicating Vector (Tocagen Toca 511) to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
Phase: Phase 1
Treatment ID#: 2033        
Age Group: Adults Only
Min Karnofsky Score: 70: Cares for self, unable to perform normal activity or to do active work
Conditions: Prior Surgery is Allowed
Prior Radiation is Allowed
Prior Chemotherapy is Allowed
Last Updated: 07/16/2012
Tumor Types: Anaplastic Astrocytoma
Any Malignant Brain Tumor
Glioblastoma Multiforme
Oligodendroglioma High Grade
Recurrent Malignant Pediatric Brain Tumors
Treatment Type: Surgery
Gene Therapy
Contact: Dr.Tom MikKelsen MD, FRCP(C)
Henry Ford Hospital
Hermelin Brain Tumor Center
E&R3096 Henry Ford Hospital 2799 West Grand Blvd
Detroit, MI 48202- USA
Phone: 313 916-8641
Fax: 313 916-9855
  • Last updated refers to the date when our listing for each treatment was last updated.
  • ID is a combination of our internal ID and the official ID for the trial, if any.
  • Min Karnofsky is a general guide to how well you have to function to use this treatment

Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure NovoTTF-100A | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book

Copyright (c) 1993 - 2015 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557

Website Design By
World Wide Websites